Portfolio company
Dermira
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arcutis Biotherapeutics
This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.
Brickell Biotech
This pharmaceutical company develops prescription therapeutics for patients with skin diseases, such as hyperhidrosis, atopic dermatitis, and acne.
Arcutis
This company develops and commercialises topical treatments for patients living with chronic immune-mediated dermatological diseases including psoriasis, seborrhoeic dermatitis and atopic dermatitis.
DermBiont
This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.
Carpe
This company develops and sells topical antiperspirant and sweat-absorbing products for individuals experiencing excessive sweating or hyperhidrosis across various body areas.
Journey Medical
This pharmaceutical company develops and sells prescription medicines to treat dermatological conditions, such as rosacea and acne, for patients and healthcare professionals.
Krystal Biotech
This biotechnology company develops and commercialises redosable gene therapies for patients with rare genetic diseases, including dystrophic epidermolysis bullosa.
DICE Therapeutics
This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.
